New weight loss shot TE-8105 tested in early human trial
Disease control
Completed
This early-phase study tested a new drug called TE-8105 in 38 overweight or obese adults without diabetes. The main goal was to see if the drug is safe and how the body processes it. Participants received one or more injections of TE-8105 at different doses. The study is complete…
Phase: PHASE1, PHASE2 • Sponsor: Immunwork, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC